Lori Sakoda to Bevacizumab
This is a "connection" page, showing publications Lori Sakoda has written about Bevacizumab.
Connection Strength
0.035
-
Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2017 03; 18(2):189-197.e3.
Score: 0.035